Now the 3rd leading cause of cancer deaths, pancreatic cancer affects ~54K Americans annually, ~104K in the EU — & each year, the US spends $4B+ on pancreatic cancer care alone. Survival rates have remained static over the last 40 years, in large part due to the difficulty in treating the disease. Most pancreatic tumors can't be removed easily through surgery by the time they are discovered & are resistant to standard chemo treatments. PanTher designed its transformative therapeutic platform to be implanted directly onto the tumor through an open or laparoscopic surgery where it will provide constant, tailored drug delivery over weeks to months — when it biodegrades to be absorbed by the body. PanTher's simple, elegant way to deliver powerful drugs directly to the tumor has the potential to change both the health outcomes and economics associated with this devastating disease, and dramatically improve the quality of life for patients.
Now the 3rd leading cause of cancer deaths, pancreatic cancer affects ~54K Americans annually, ~104K in the EU — & each year, the US spends $4B+ on pancreatic cancer care alone. Survival rates have remained static over the last 40 years, in large part due to the difficulty in treating the disease. Most pancreatic tumors can't be removed easily through surgery by the time they are discovered & are resistant to standard chemo treatments. PanTher designed its transformative therapeutic platform to be implanted directly onto the tumor through an open or laparoscopic surgery where it will provide constant, tailored drug delivery over weeks to months — when it biodegrades to be absorbed by the body. PanTher's simple, elegant way to deliver powerful drugs directly to the tumor has the potential to change both the health outcomes and economics associated with this devastating disease, and dramatically improve the quality of life for patients.